Table 3.
Univariate and multivariate survival analysis of prognostic factors in MPM patients
| Characteristics | OS rate (%) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
| 1Y | 5Y | P value | HR(95 % CI) | P value | |
| Age(years) | 0.95 | 1.16(0.61-2.21) | 0.65 | ||
| <70Y | 94 % | 68 % | |||
| > = 70Y | 91 % | 67 % | |||
| Gender | 0.15 | 1.05(0.54-2.03) | 0.89 | ||
| Male | 90 % | 66 % | |||
| Female | 98 % | 70 % | |||
| Smoking status | 0.28 | 0.74(0.38-1.45) | 0.38 | ||
| Never smoker | 95 % | 70 % | |||
| Smoker | 88 % | 63 % | |||
| Stage for lung cancer | <0.001 | 1.66(1.38-2.03) | <0.001 | ||
| I | 93 % | 91 % | |||
| II | 100 % | 79 % | |||
| III | 95 % | 55 % | |||
| IV | 88 % | 55 % | |||
| Treatment for other cancers | 0.14 | 1.21(0.75-1.95) | 0.44 | ||
| Curative | 94 % | 75 % | |||
| Palliative | 92 % | 63 % | |||
| Histological type | 0.16 | 1.14(0.92-1.43) | 0.24 | ||
| Adenocarcinoma | 93 % | 69 % | |||
| Squamous cell carcinoma | 93 % | 67 % | |||
| SCLC | 88 % | 53 % | |||
| Other NSCLC | 100 % | 86 % | |||
| Time of occurrence | <0.001 | 0.19(0.10-0.36) | <0.001 | ||
| Synchronous | 80 % | 61 % | |||
| metachronous | 100 % | 71 % | |||
| Order of occurrence | 0.047 | 0.85(0.49-1.47) | 0.56 | ||
| LCF | 88 % | 63 % | |||
| OCF | 94 % | 69 % | |||
OS Overall Survival; HR Hazard Ratio; CI Confidence Interval